Cipla USA recalls

Cipla USA has 23 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 8 Jul 2026. 21 are still ongoing. 17 were reported in the last 12 months. The most frequent reason is nitrosamine impurity.

Total recalls23since 2023

Last 12 months17reported

Class I14% of total

Ongoing21latest 8 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 2 0 0Jan '25 0 0 0Apr 0 0 1Jul 1 0 0Oct 0 5 2Jan '26 0 2 5Apr 0 0 3Jul 0 0

Severity split

Class I 1 4%Class II 18 78%Class III 4 17%

Why cipla usa is recalled

Product types

Brands

Cinacalcet939%
Lanreotide Acetate313%
Albuterol Sulfate29%
Lanthanum Carbonate29%
Nilotinib29%
Ipratropium Bromide And Albuterol Sulfate14%
Budesonide14%
Diclofenac Sodium14%

By year

20261252%
2025730%
2024313%
202314%

Ongoing cipla usa recalls

21 active

Reported	Class	Recall	Company	Reason	Where
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide

All cipla usa recalls, newest first

23 total

Reported	Class	Recall	Company	Reason	Where
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
15 Apr 2026Drug	CLASS II	Lanreotide Injection, 120 mg* recalled by Cipla USALanreotide Acetate	Cipla USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	Lanreotide Injection, 120 mg recalled by Cipla USALanreotide Acetate	Cipla USA	Sterility	Nationwide
11 Mar 2026Drug	CLASS III	Nilotinib Capsules recalled by Cipla USANilotinib	Cipla USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS III	Nilotinib Capsules recalled by Cipla USANilotinib	Cipla USA	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.